Search results
Results From The WOW.Com Content Network
Biocompatibles International plc was a medical technology company in the field of drug-device combination products. It was acquired by BTG plc in 2010, [2] which was, in turn, acquired by Boston Scientific in 2019.
Boston Scientific: Guidant: 24.6 38 With the lower re-negotiated a lower price of $21.5 billion between Johnson & Johnson and Guidant, Boston Scientific announced an unsolicited offer of $24.6 billion for Guidant (an offer of $72 per share of Guidant, $36 in cash and a fixed number of Boston Scientific shares valued at $36 a share). 26 2006
Boston Scientific acquired Target Therapeutics in a tax-free stock swap for about $1.1 billion, more than 10 times Target's total sales, in contrast to the usual multiple of 10 times earnings. [14] The Taxus Stent was approved in 2003 in Europe and other countries and, in the United States, by the FDA in March 2004.
For premium support please call: 800-290-4726 more ways to reach us
Boston Scientific announced on Jan. 21 that it is set to acquire the privately-held Preventice Solutions. The transaction will consist of an upfront cash payment of $925 million and an additional ...
Per Reuters and The Wall Street Journal, Stryker (SYK) is likely to acquire Boston Scientific. However, there are no confirmatory statements from the company representatives.
In May 2016 BTG plc acquired the Israeli company Galil Medical for US$110 million. [9] In September 2018, BTG plc acquired Novate Medical for up to $150 million. [10] In late November 2018 Boston Scientific announced it would acquire BTG for $4.2 billion. [11] The transaction was due to complete in August 2019. [12]
Apollo 10 (May 18–26, 1969) was the fourth human spaceflight in the United States' Apollo program and the second to orbit the Moon. NASA, the mission's operator, described it as a "dress rehearsal" for the first Moon landing (Apollo 11, two months later [4]).